How Automation, Analytics, And AI Can Assist Safety Signal Management

Signal management in pharmacovigilance faces mounting pressure from expanding data sources, increasingly complex biologics, and stringent regulatory demands. Traditional statistical methods like proportional reporting ratios flag potential associations but weren't designed as decision-making tools—they struggle with reporting bias, can't systematically incorporate prior knowledge, and produce inconsistent results across review teams. Meanwhile, safety professionals spend substantial time on manual data cleaning and case triage rather than meaningful risk assessment. Natural language processing can extract clinical insights from unstructured narratives, while Bayesian approaches allow formal integration of mechanistic knowledge with emerging data. AI-based pattern recognition identifies cross-product safety trends that manual review might miss. The path forward isn't full automation but augmentation: human-in-the-loop systems handle routine tracking and documentation while preserving expert judgment for interpretation. This allows constrained safety teams to focus on what matters most—protecting patients through rigorous, timely benefit-risk decisions.